Catalyst Wire Dossier Catalyst Wire Dossier

Fulvestrant Injection 50 mg/mL

fulvestrant · Fresenius Kabi
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Fulvestrant Injection 50 mg/mL, covering 2017-03-09 to 2017-03-09. Get the full timeline:

Most recent: Clinical Trial Update: Bioequivalence Study of Fulvestrant Injection 50 mg/mL in Healthy Post-menopausal Female Subjects [Phase 1]

See pricing